Sociodemographic, Constitutional Risk Factors Associated with Likelihood of Skin Examinations
the Cancer Therapy Advisor take:
The likelihood of recent screening for skin cancer among individuals was strongly associated with sociodemographic and constitutional risk factors, according to an article published online in the journal Cancer Epidemiology, Biomarkers & Prevention.
In this study, 50,044 participants of the California Twin Program self-reported data regarding prevalence and determinants of recent clinical screening for skin cancer.
Results showed the reported prevalence of skin examination (32% of participants across all ages reported having a skin examination) was greater than the national estimates.
Major factors significantly associated with recent screening included white race, highest level of education, marital status, number of large moles, and both individual and family history of skin cancer.
Whereas, lower socioeconomic status, racial minority status, and frequent UV-related risk behaviors throughout adulthood correlated to a lower likelihood of recent screening among participants.
The likelihood of recent screening for skin cancer among individuals strongly associated with sociodemographic and constitutional risk factors.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Pancreatitis and the Risk of Cancer
- RAMIE May Improve Post-operative Outcomes Among Patients With Esophageal Cancer
- Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery Prolongs OS in Gastric Cancer
- Renal Cell Carcinoma: Cost of Treatment May Negate Impact of Treatment Advances
- Pembrolizumab May Be Effective for Previously Treated Hepatocellular Carcinoma
- CTC Screening May Be Effective Method for Preventing Colorectal Cancer
- Physical Activity Intervention May Improve Functional Well-being Among CRC Survivors
- Atezolizumab With Cobimetinib Yields Partial Response in Small Number of Patients With CRC
- Nivolumab May Improve Long-term Complete Response Rate in Subset of Patients With mCRC
- Alcohol Consumption and Cancer